financetom
Business
financetom
/
Business
/
US banks report 13.5% jump in profits: FDIC
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US banks report 13.5% jump in profits: FDIC
Nov 24, 2025 7:06 AM

WASHINGTON, Nov 24 (Reuters) - The U.S. banking industry

saw its profits jump 13.5% to $79.3 billion in the third quarter

of 2025, the Federal Deposit Insurance Corporation reported

Monday.

The FDIC said the stronger profits were primarily due to

growth in non-interest income expense, as well as banks booking

smaller loss provision expenses. In the second quarter, the

banking sector reported higher provision expenses, primarily

thanks to the completed merger of Capital One and Discover

Financial.

While the banking sector remained healthy overall, the

regulator flagged the industry is still grappling with

historically high past-due rates on some types of loans, notably

commercial real estate, auto and credit card loans.

Banks with over $250 billion in assets reported a past-due

rate of 4.18% for non-owner occupied commercial real estate

loans. That figure is down from a 4.99% peak of a year prior,

but still well above the pre-pandemic average of 0.59%. The

overall past-due rate held steady at 1.49% of total loans, which

is below the pre-pandemic average of 1.94%.

"The banking industry continued to have strong capital and

liquidity levels, which support lending and protect against

potential losses," said acting FDIC Chairman Travis Hill in

prepared remarks.

Banks reported a fifth straight quarter of higher deposits,

boosted by $88.6 billion more in additional uninsured deposits,

a 1.1% jump from the prior quarter. The number of "problem

banks," which are banks that have low supervisory ratings,

dropped by 2 to 57 banks, and the total number of banks in the

country fell by 42 due to sales or mergers.

(Reporting by Pete Schroeder; Editing by Chizu Nomiyama )

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved